The Valley Desk

ArticleCancerPublished

Should patients with hormone receptor-positive, HER2-negative breast cancer and one or two positive sentinel nodes undergo axillary dissection to determine candidacy for adjuvant abemaciclib?

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Cancer
Published
Subject terms
Axilla; Lymph Nodes; Humans; Breast Neoplasms; Lymphatic Metastasis; Aminopyridines; Benzimidazoles; Sentinel Lymph Node Biopsy; Lymph Node Excision; Female; Sentinel Lymph Node; Breast cancer
PubMed ID
38018862
PubMed Central ID
PMC11422773
Added to directory
Source checked

Report a correction or request removal